Tufts Medical Center
800 Washington St, #324
Boston, MA 02111
Phone #: 617-636-2382
Fax #: 617-636-8315
2020, "Top Doctor," Boston Magazine
2019, Appointed President-Elect, Council of University Chairs of Obstetrics & Gynecology (CUCOG)
2019, Member, Board of Scientific Counselors, NICHD, Bethesda, MD
2017, Rochester General Hospital Association Teaching Fellowship, Department of OB/GYN, Rochester General Hospital, Rochester, NY
2011-present, Top Doctors in Boston
2011, The March of Dimes Award for Best Research in Prematurity at SMFM, San Francisco, CA
2011, Best Oral Presentation at SMFM, San Francisco, CA
2009, Best Doctors in Connecticut
2008, Best Oral Presentation at SMFM, Dallas, TX
2007, Fellow, American Gynecological and Obstetrical Society (AGOS)
2007-2011, America’s Top Obstetricians and Gynecologists, Consumer’s Research Council of America
2006-present, Fellow, Timothy Dwight College, Yale College, New Haven, CT
2006, The Charles A. Hunter Jr. Prize Thesis Award, 25th Annual Meeting of American Gynecological and Obstetrical Society, Williamsburg, VA
2006, The March of Dimes Award for the Best Research in Prematurity at SMFM, Miami, FL
2005-present, Best Doctors in America
2005, Best Poster Presentation at SMFM, Reno, NV
2004, The Zuspan Award for the Best Oral Presentation, Society for Obstetric Anesthesia and Perinatology (SOAP), Ft. Myers, FL
2003, Best Oral Presentation at SMFM, New Orleans, LA
2002, Best Oral Presentation at ACOG Distinct I Annual Meeting, Southampton, Bermuda
2001, Rochester General Hospital Association Teaching Fellowship, Department of OB/GYN, Rochester General Hospital, Rochester, NY
2000, Best Oral Presentation at the New England Perinatal Society, Manchester Village, VT
1999, Quest Diagnostics Award for Best Oral Presentation, The Endocrine Society, San Diego, CA
1999, Best Oral Presentation at New England Conference on Perinatal Research, Chatham, MA
1991, Best Poster Presentation at the 2nd European Congress on Prostaglandins in Reproduction, The Hague, the Netherlands
1988-1991, The Rhodes Scholarship (Southern Africa at Large), Oxford University, UK
FOR A COMPLETE LIST OF DR. NORWITZ’S PUBLICATIONS, SEE: PubMed
"Women's Health Without Borders" [panel discussion] Magee-Womens Research Summit, David L. Lawrence Convention Center, Pittsburgh, PA, October, 2018.
“How to interpret cord blood gases;” “Optimal timing of delivery: Should it be 39 weeks and out?”; “Obesity in pregnancy”; and “Management of preeclampsia,”36th Annual Fall Conference on Obstetrics, Symposia Medicus, JW Marriott Guanacaste Resort & Spa, Guanacaste, Costa Rica, October, 2018.
"Is there a role of genetic testing to predict pregnancy complications?" Illumina, Reproductive and Genetic Health Clinical Expert Panel, Montreal, Canada, September, 2018.
"New guidelines on thromboprophylaxis in pregnancy;" and "Morbid obesity in pregnancy: a growing problem;" 17th Annual Congress of the Society of Obstetrics and Gynecology of Romania (SOGR), Iaci, Romania, September, 2018.
“10 things I wish someone had told me before I became Chair;” and “Professional Development: Achieving clinical and academic excellence in a time of diminished resources;” 3rd Biannual ACOG Course on Essentials for the New Ob-Gyn Department Chair, ACOG, Washington, DC, August, 2018.
“Preterm birth: A global healthcare pandemic in search of an integrated solution,” 3rd Annual Rhodes Healthcare Forum: Forward Together: Approaching Global Inequities in Health, Rhodes House, Oxford, UK November, 2017.
“Prenatal diagnosis of placental diseases: role of ultrasound;” “SLE: preconception counseling and perinatal management;” and “Management of thyroid disease in pregnancy;” The Third China-U.S. Forum on Women and Children’s Healthcare, Nanning, Guangxi Province, PR China, July, 2017.
“Molecular regulation of adverse pregnancy outcome: Inflammation and the decidual clock,” Pre-ASRI Annual Meeting Clinical Symposium, 36th Annual Scientific Meeting of the American Society for Reproductive Immunology, Baltimore, MD, November, 2016.
“Obesity in pregnancy;”“Management dilemmas of the post-term pregnancy;” “Preterm labor: Mechanisms and management;” and “Endocrine emergencies in the pregnant patient,” 34th Annual Fall Conference on Obstetrics, Symposia Medicus, Westin Grand Cayman Seven Mile Beach Resort & Spa, Grand Cayman, Cayman Islands, October, 2016.
Errol Norwitz, MD, is internationally recognized for his work in maternal-fetal medicine, particularly in the causes and prevention of preeclampsia and pre-term labor. His research includes the use of progesterone to delay preterm labor in high-risk women, the genetics of adverse pregnancy outcomes, and the molecular regulation of labor and delivery, both term and preterm. He is the Chair of Obstetrics and Gynecology at Tufts Medical Center, and a professor at Tufts University School of Medicine. He is board certified in Maternal Fetal Medicine and Obstetrics and Gynecology.
President, Pratt Ob/Gyn, Boston, MA
Medical Board, Tufts Medical Center, Boston, MA
Research Council, Tufts Medical Center, Boston, MA
Editor-in-Chief, Reviews in Obstetrics & Gynecology
2007-2010, Member, Obstetric Practice Committee, Yale-New Haven Hospital
2007-2010, Member, Gynecology Practice Committee, Yale-New Haven Hospital
2003-2010, Member, Quality Assessment Comm., Dept. of Ob/Gyn. & Repr. Biology, Yale-New Haven Hospital
2003, Chair, Mortality & Morbidity Conf., Dept. of Ob/Gyn. & Repr. Sciences, Yale-New Haven Hospital
Measuring early pregnancy glycemia and its impact on adverse outcomes.
This is a prospective observational study to examine glucose physiology and biomarkers of glycemic control throughout gestation and their effect on pregnancy outcomes.
Illumina, Inc. I.D. #: RGH-015
Prospective collection of whole blood specimens in pregnant women.
The goal of this study is to develop the next generation of noninvasive prenatal tests for the detection of genetic abnormalities in the fetus and placental diseases.
Illumina, Inc. I.D. #: RGH-014
Prospective collection of whole blood specimens of subjects diagnosed with preterm preeclampsia and/or fetal growth restriction in support of a molecular assay development
The major goals of this project are to identify novel serum biomarkers for the prediction and/or diagnosis of placental disease disorders, including preeclampsia and IUGR
Hologic, Inc. I.D.#: Protocol #10Q01
Prospective phase III evaluation of fetal fibronectin in a high risk asymptomatic population for the prediction of spontaneous preterm birth.
The aim of this study was to test the ability of quantitative fFN testing at 16-20 weeks of gestation to identify women who will go on to have a spontaneous preterm birth using a cohort of 1,300 women in 20 centers across the U.S.
Role: PI and Site-PI
Neonatal foreskin tissue donation program.
The goal of this study was to optimize the use of neonatal foreskin tissues as allogeneic skin grafts
University of Massachusetts Center for Clinical and Translational Science
UL1TR000161, National Center for Advancing Translational sciences, NIH
Soy protein and isoflavone supplementation for improved glucose metabolism and lipid profiles in pregnant women at high risk for gestational diabetes mellitus.
The goal of this project was to investigate the effect on dietary supplementation with soy protein on glycemic control and lipid profile in pregnant women at high risk of GDM.
Innate Immune Responses of Trophoblasts in Pregnancy.
The major goals of this project are to determine the regulation of TLR-2 and TLR-8 mediated inflammation and apoptosis in the normal first trimester trophoblast in response to bacterial and viral components.
Program: Function of Toll-Like Receptors Throughout Gestation.
Project: Role of Toll-Like Receptors and Glucocorticoid in Placental-Fetal Inflammation.
The major goals of this project are to understand the function of Toll-like receptors at the maternal-fetal interface throughout gestation, and their role in infection-associated pregnancy complications. These studies will focus on the inflammatory
function of TLRs 3 and 4 in the first trimester placenta (Project I) and the inflammatory function of TLRs 2, 3 and 4 in the decidua (Project II) and term placenta (Project III).
Burroughs Wellcome Fund
The Role of Placental Nod-Like Receptors in Infection-Associated Preterm Labor.
The major goals of this project are to determine the function of NLRs in the placenta and their role in infection-associated preterm labor.
March of Dimes
Progesterone Receptor Dysregulation and Preterm Birth.
To understand in detail the molecular mechanisms by which progesterone supplementation can prevent preterm birth in some high-risk parturients and, in particular, to characterize the role of the progesterone receptor in spontaneous preterm labor.
Role: Principal Investigator.
Vision Grant Award (Panda)
Role of TLR in Preeclampsia.
The major goal of this project was to delineate the role of TLR in the pathogenesis of preeclampsia.
A Proteomics Computational Approach to Preterm Delivery.
Uses proteomics and computational tools to classify pathogenetic entities within the preterm labor syndrome and identifies biomarkers with diagnostic and prognostic value.